GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Purchase Of Investment

Curocell (XKRX:372320) Purchase Of Investment : ₩ Mil (TTM As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Curocell Purchase Of Investment?

Curocell's purchase of investment for the six months ended in Jun. 2023 was ₩-26,900.00 Mil. It means Curocell spent ₩26,900.00 Mil on purchasing investments.

Compared with last quarter (₩-47,000.00 Mil in Dec. 2022 ), Curocell spent less money on purchasing investments in Jun. 2023 (₩-26,900.00 Mil).


Curocell Purchase Of Investment Historical Data

The historical data trend for Curocell's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Purchase Of Investment Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Purchase Of Investment
-8,800.00 -37,601.25 -57,300.00 -95,500.00 -56,900.00

Curocell Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Purchase Of Investment -48,500.00 -47,000.00 -26,900.00 -30,000.00

Curocell Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.


Curocell Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Curocell's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Curocell (XKRX:372320) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines